6600 — SciClone Pharmaceuticals (Holdings) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Market Cap
HK$11.81bn
Enterprise Value
HK$9.70bn
Revenue
CNY3.16bn

Annual balance sheet for SciClone Pharmaceuticals (Holdings), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,043	1,189	2,188	1,875	2,223
Net Total Accounts Receivable
Net Total Receivables	363	325	547	781	893
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,572	1,909	2,999	3,600	3,447
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	35.1	14.3	29.9	28.6	39.4
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,846	2,883	4,063	4,320	4,000
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	307	1,388	957	891	698
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	321	2,571	1,745	1,328	735
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,525	312	2,317	2,992	3,265
Total Liabilities & Shareholders' Equity	1,846	2,883	4,063	4,320	4,000
Total Common Shares Outstanding